Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • AI and healthcare
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
      • Top Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • AI and healthcare
    • Industry Perspective
  • Home
  • Nephrology
  • Nephrology News
  • Renal Allograft...

Renal Allograft Embolization Safer Alternative for Failed Kidney Allografts with Key Precautions, Reveals Research

Written By : Medha Baranwal |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2026-04-27T21:00:43+05:30  |  Updated On 28 April 2026 10:51 AM IST
Renal Allograft Embolization Safer Alternative for Failed Kidney Allografts with Key Precautions, Reveals Research
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Netherlands: Researchers have found in a new study that percutaneous renal artery embolization for failed kidney allografts is associated with shorter hospital stays and potentially fewer major complications compared to graft nephrectomy. Achieving complete hemostasis, confirmed by angiography, is essential to reduce the risk of persistent graft intolerance. However, the presence of pre-existing sepsis or recent graft infection should be considered a contraindication to embolization, emphasizing careful patient selection.

These findings are from a retrospective cohort study published in Clinical Transplantation by Mattheüs F. Klaassen and colleagues from the Erasmus MC Transplant Institute. The study explored outcomes in kidney transplant recipients who developed graft intolerance after transplant failure—a condition in which the retained non-functioning graft triggers immune-related symptoms.
Traditionally, surgical removal of the failed graft, known as nephrectomy, has been the standard approach. However, this procedure carries considerable risks, including complications related to surgery and prolonged recovery. As a result, less invasive alternatives such as renal artery embolization—where blood supply to the graft is blocked—are being increasingly evaluated.
For this study, researchers analyzed patients treated between 2018 and 2024, including 13 who underwent embolization and 32 who received graft nephrectomy. The team assessed key outcomes such as major complications within three months, duration of hospitalization, need for blood transfusions, readmissions, and mortality.
The following were the key findings of the study:
  • Percutaneous renal artery embolization showed a potentially safer profile in selected patients compared to graft nephrectomy.
  • Major complications were observed in 23% of patients undergoing embolization versus 41% in those undergoing nephrectomy, though this difference was not statistically significant.
  • Hospital stay was significantly shorter with embolization, with a median duration of 1 day compared to 5 days for surgical removal.
  • Post-embolization syndrome occurred in nearly 70% of cases and typically presented with mild symptoms such as fever and pain, which were managed conservatively.
  • Some patients required subsequent nephrectomy due to complications, including infected graft necrosis and persistent bleeding resulting from incomplete embolization.
  • Outcomes were worse in patients with pre-existing infections.
  • Two patients with sepsis and bacteremia died after undergoing embolization.
  • Recent graft infection was identified as a contraindication to embolization, highlighting the importance of careful patient selection.
While the findings support embolization as a promising alternative to surgery, the authors caution that their conclusions are based on a relatively small sample and retrospective analysis. Differences in baseline characteristics, including higher comorbidity in the embolization group, may also influence outcomes.
Overall, the study suggests that renal artery embolization could reduce hospital burden and complication rates in selected patients with failed kidney grafts. However, further large-scale prospective studies are needed to better define its role, including whether it could be used earlier in the disease course to prevent graft intolerance.
Reference:
Klaassen, M. F., Otterspeer, J., Heidt, S., Kimenai, D., Pieterman, K. J., & Minnee, R. C. (2026). Graft Embolization versus Nephrectomy in Patients with Graft Intolerance and Infection: A Retrospective Cohort Study. Clinical Transplantation, 40(4), e70542. https://doi.org/10.1111/ctr.70542
Clinical Transplantationgraft embolizationnephrectomygraft intolerance
Source : Clinical Transplantation
Medha Baranwal
Medha Baranwal

    MSc. Biotechnology

    Medha Baranwal holds a Bachelor’s degree in Biomedical Sciences from the University of Delhi and a Master’s degree in Biotechnology from Amity University. Since May 2018, she has been contributing to Medical Dialogues, writing and editing medical news articles that translate complex research into clear, accessible information for healthcare professionals.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Comparing Telmisartan Amlodipine FDC vs. Telmisartan Cilnidipine FDC in Indian Hypertensive Patients: Latest START RENAL 2026 Update

    Comparing Telmisartan Amlodipine FDC vs. Telmisartan Cilnidipine FDC in Indian Hypertensive...

    Dapagliflozin Metformin in T2D: Six Potential Benefits Beyond Glucose Lowering-Dr Setu Gupta

    Dapagliflozin Metformin in T2D: Six Potential Benefits Beyond Glucose Lowering-Dr Setu Gupta

    Merck Marks Beta Blocker Month: Revisiting a Landmark Discovery & Spotlight on Bisoprolol

    Merck Marks Beta Blocker Month: Revisiting a Landmark Discovery & Spotlight on Bisoprolol

    CKM Syndrome Stage 1: Why Obesity Is No Longer a Cosmetic Problem

    CKM Syndrome Stage 1: Why Obesity Is No Longer a Cosmetic Problem

    Dapagliflozin in Heart Failure: Cardiologists Practical Perspective

    Dapagliflozin in Heart Failure: Cardiologist's Practical Perspective

    View All

    Journal Club Today

    New Study Questions Brain Health Benefits of Omega-3 Fish Oil Supplements

    New Study Questions Brain Health Benefits of Omega-3 Fish Oil Supplements

    View All

    Health News Today

    Health Bulletin 01/July/2026

    Health Bulletin 01/July/2026

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok